Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.001 Par Value
-
Shares outstanding
-
117M
-
Number of holders
-
160
-
Total 13F shares, excl. options
-
122M
-
Shares change
-
-255K
-
Total reported value, excl. options
-
$1.32B
-
Value change
-
+$425K
-
Put/Call ratio
-
0.73
-
Number of buys
-
81
-
Number of sells
-
-65
-
Price
-
$10.80
Significant Holders of Cogent Biosciences, Inc. - Common Stock, $0.001 Par Value (COGT) as of Q3 2024
184 filings reported holding COGT - Cogent Biosciences, Inc. - Common Stock, $0.001 Par Value as of Q3 2024.
Cogent Biosciences, Inc. - Common Stock, $0.001 Par Value (COGT) has 160 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 122M shares
.
Largest 10 shareholders include Point72 Asset Management, L.P. (10.5M shares), Kynam Capital Management, LP (9.24M shares), FMR LLC (8.32M shares), BlackRock, Inc. (7.99M shares), COMMODORE CAPITAL LP (7.54M shares), TCG Crossover Management, LLC (6.96M shares), Fairmount Funds Management LLC (6.23M shares), VANGUARD GROUP INC (5.71M shares), VR Adviser, LLC (5.68M shares), and Paradigm Biocapital Advisors LP (4.61M shares).
This table shows the top 160 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.